Lesson plan
2C2-NBOMe
2C2-NBOMe, also known as 2C-MMDA-2-NBOMe or NBOMe-MMDPEA-2, is a phenethylamine derivative from the 25-NB (NBOMe) family. It is the NBOMe derivative of 2C-MMDA-2 (MMDPEA-2). It acts as a potent agonist at the serotonin 5-HT 2A receptor with weaker activity at 5-HT 2B and 5-HT 2C , and produces a head-twitch response in animal studies which often correlates with potential for psychedelic effects in humans. It is related in structure to psychedelic phenethylamine derivatives such as MMDA-2 and lophophine (MMDPEA) and is the first phenethylamine derivative with a methylenedioxy substitution on the phenyl ring but no alkyl substitution on the alpha carbon, that has been shown to produce psychedelic-appropriate responding in animals. The drug was first described in the literature by Jason Wallach and colleagues in 2022 and 2023. It is a controlled substance in Canada under phenethylamine blanket-ban language. The drug is not an explicitly controlled substance in the United States, but could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.
Article summary
2C2-NBOMe, also known as 2C-MMDA-2-NBOMe or NBOMe-MMDPEA-2, is a phenethylamine derivative from the 25-NB (NBOMe) family. It is the NBOMe derivative of 2C-MMDA-2 (MMDPEA-2). It acts as a potent agonist at the serotonin 5-HT 2A receptor with weaker activity at 5-HT 2B and 5-HT 2C , and produces a head-twitch response in animal studies which often correlates with potential for psychedelic effects in humans. It is related in structure to psychedelic phenethylamine derivatives such as MMDA-2 and lophophine (MMDPEA) and is the first phenethylamine derivative with a methylenedioxy substitution on the phenyl ring but no alkyl substitution on the alpha carbon, that has been shown to produce psychedelic-appropriate responding in animals. The drug was first described in the literature by Jason Wallach and colleagues in 2022 and 2023. It is a controlled substance in Canada under phenethylamine blanket-ban language. The drug is not an explicitly controlled substance in the United States, but could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.